Arpaci, Fikret <br/><br/>
The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer.  [electronic resource] 

 -  Journal of clinical apheresis  2009 
 - 197-204 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-1101 
<br/><br/><label>Standard No.: </label>10.1002/jca.20211  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Blood Component Removal<br/>Bone Marrow Cells--pathology<br/>Breast Neoplasms--mortality<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Neoplastic Cells, Circulating--pathology<br/>Survival Rate